Optimal first-line treatment for platinum-eligible metastatic urothelial carcinoma Comparison of chemo-immunotherapy, immunotherapy, and chemotherapy- A systematic review and meta-analysis

Optimal first-line treatment for platinum-eligible metastatic urothelial carcinoma : Comparison of chemo-immunotherapy, immunotherapy, and chemotherapy- A systematic review and meta-analysis

Copyright © 2022. Published by Elsevier Inc.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 236(2022) vom: 01. März, Seite 108927
1. Verfasser: Li, Haifeng (VerfasserIn)
Weitere Verfasser: Ni, Mengqian, Xue, Cong, Li, Lu, Huang, Riqing, Yang, Wei, Hu, Anqi, An, Xin, Shi, Yanxia
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review Immune Checkpoint Inhibitors Programmed Cell Death 1 Receptor Platinum 49DFR088MY
Online verfügbar Volltext